IMMX
IMMIX BIOPHARMA INC
CUSIP: 45258H106
IMMIX BIOPHARMA INC (IMMX) — institutional ownership and SEC 13F holdings data. Source: SEC EDGAR 13F filings.
About
Immix Biopharma Inc is a small development-stage biopharmaceutical company focused on creating novel therapies in oncology and immune-related diseases. The company advances a pipeline of preclinical and clinical-stage drug candidates, concentrating on research, clinical development and regulatory milestones rather than product sales. As a development-stage biotech, it typically relies on financing and partnerships to fund R&D and progress candidates toward commercialization.
Institutional Holders
Source: SEC EDGAR 13F-HR filings from institutional investment managers.
AI Agent
Try asking...